BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

79 related articles for article (PubMed ID: 30277154)

  • 1. Design, Synthesis and Antileishmanial Activity of Naphthotriazolyl-4- Oxoquinolines.
    Oliveira VG; Dos Santos Faiões V; Gonçalves GBR; Lima MFO; Boechat FCS; Cunha AC; de Andrade-Neto VV; de C da Silva F; Torres-Santos EC; de Souza MCBV
    Curr Top Med Chem; 2018; 18(17):1454-1464. PubMed ID: 30277154
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparing the Antileishmanial Activity of Gold(I) and Gold(III) Compounds in L. amazonensis and L. braziliensis in Vitro.
    Minori K; Rosa LB; Bonsignore R; Casini A; Miguel DC
    ChemMedChem; 2020 Nov; 15(22):2146-2150. PubMed ID: 32830445
    [TBL] [Abstract][Full Text] [Related]  

  • 3. In vitro Evaluation of the Antileishmanial and Antischistosomal Activities of p-Coumaric Acid Prenylated Derivatives.
    Vieira TM; Barco JG; Paula LAL; Felix PCA; Bastos JK; Magalhães LG; Crotti AEM
    Chem Biodivers; 2024 May; 21(5):e202400491. PubMed ID: 38470945
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Benzimidazole derivatives endowed with potent antileishmanial activity.
    Tonelli M; Gabriele E; Piazza F; Basilico N; Parapini S; Tasso B; Loddo R; Sparatore F; Sparatore A
    J Enzyme Inhib Med Chem; 2018 Dec; 33(1):210-226. PubMed ID: 29233048
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Insights into the structural patterns of the antileishmanial activity of bi- and tricyclic N-heterocycles.
    Herrera L; Stephens DE; D'Avila A; George KG; Arman H; Zhang Y; Perry G; Lleonart R; Larionov OV; Fernández PL
    Org Biomol Chem; 2016 Aug; 14(29):7053-60. PubMed ID: 27376396
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The Brown Alga Stypopodium zonale (Dictyotaceae): A Potential Source of Anti-Leishmania Drugs.
    Soares DC; Szlachta MM; Teixeira VL; Soares AR; Saraiva EM
    Mar Drugs; 2016 Sep; 14(9):. PubMed ID: 27618071
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Spiro-Acridine Compound as a Pteridine Reductase 1 Inhibitor: in silico Target Fishing and in vitro Studies.
    de Oliveira Viana J; Sena Mendes M; Santos Castilho M; Olímpio de Moura R; Guimarães Barbosa E
    ChemMedChem; 2024 Jun; 19(11):e202300545. PubMed ID: 38445815
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Leishmanicidal activity and 4D quantitative structure-activity relationship and molecular docking studies of vanillin-containing 1,2,3-triazole derivatives.
    Rodrigues Gazolla PA; Lima WP; de Aguiar AR; Gonçalves Borsodi MP; Costa AV; de Oliveira FM; de Oliveira OV; Andreazza Costa MC; Castro Ferreira MM; do Nascimento CJ; Junker J; Vaz BG; Teixeira RR
    Future Med Chem; 2024 Jan; 16(2):139-155. PubMed ID: 38131191
    [No Abstract]   [Full Text] [Related]  

  • 9. Design, synthesis, and biological evaluation of quinoline-piperazine/pyrrolidine derivatives as possible antileishmanial agents.
    Katiyar S; Ramalingam K; Kumar A; Ansari A; Bisen AC; Mishra G; Sanap SN; Bhatta RS; Purkait B; Goyal N; Sashidhara KV
    Eur J Med Chem; 2023 Dec; 261():115863. PubMed ID: 37837672
    [TBL] [Abstract][Full Text] [Related]  

  • 10. One-pot synthesis of polyhydroquinoline-1,2,3-triazole hybrids in deep eutectic solvent as anti-leishmanial agents and molecular modeling studies.
    Molaei S; Farhadi G; Talezari M; Gholizadeh N; Mahnam K; Keivanloo A; Sepehri S
    J Biomol Struct Dyn; 2024 Jun; 42(9):4834-4850. PubMed ID: 37325813
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Synthesis, characterization and evaluation of prenylated chalcones ethers as promising antileishmanial compounds.
    Hernández-Rivera JL; Espinoza-Hicks JC; Chacón-Vargas KF; Carrillo-Campos J; Sánchez-Torres LE; Camacho-Dávila AA
    Mol Divers; 2023 Oct; 27(5):2073-2092. PubMed ID: 36306047
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Antileishmanial activity of 5-nitroindazole derivatives.
    Mollineda-Diogo N; Chaviano-Montes de Oca CS; Sifontes-Rodríguez S; Espinosa-Buitrago T; Monzote-Fidalgo L; Meneses-Marcel A; Morales-Helguera A; Perez-Castillo Y; Arán-Redó V
    Ther Adv Infect Dis; 2023; 10():20499361231208294. PubMed ID: 37915499
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Promising aryl selenoate derivatives as antileishmanial agents and their effects on gene expression.
    Fernández-Rubio C; Rubio-Hernández M; Alcolea V; Burguete-Mikeo A; Nguewa PA; Pérez-Silanes S
    Antimicrob Agents Chemother; 2024 Apr; 68(4):e0155923. PubMed ID: 38497616
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Synthesis of chalcone derivatives by Claisen-Schmidt condensation and
    Souza GB; Santos TAC; Silva APS; Barreiros ALBS; Nardelli VB; Siqueira IB; Dolabella SS; Costa EV; Alves PB; Scher R; Fernandes RPM
    Nat Prod Res; 2024 Apr; 38(8):1326-1333. PubMed ID: 36331421
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Antileishmanial Activity, Toxicity and Mechanism of Action of Complexes of Sodium Usnate with Lanthanide Ions: Eu(III), Sm(III), Gd(III), Nd(III), La(III) and Tb(III).
    da Silva F; Rizk YS; das Neves AR; Lourenço EMG; Ferreira AMT; Monteiro MM; de Lima DP; Perdomo RT; Bonfá IS; Toffoli-Kadri MC; Duarte AP; Nunes DM; Martines MAU; Piranda EM; de Arruda CCP
    Int J Mol Sci; 2023 Dec; 25(1):. PubMed ID: 38203584
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Dual Antitubercular and Antileishmanial Profiles of Quinoxaline Di-
    González JF; Dea-Ayuela MA; Huck L; Orduña JM; Bolás-Fernández F; de la Cuesta E; Haseen N; Mohammed AA; Menéndez JC
    Pharmaceuticals (Basel); 2024 Apr; 17(4):. PubMed ID: 38675447
    [TBL] [Abstract][Full Text] [Related]  

  • 17. An Antiparasitic Compound from the Medicines for Malaria Venture Pathogen Box Promotes
    Ullah I; Gahalawat S; Booshehri LM; Niederstrasser H; Majumdar S; Leija C; Bradford JM; Hu B; Ready JM; Wetzel DM
    ACS Infect Dis; 2020 Aug; 6(8):2057-2072. PubMed ID: 32686409
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Natural endoperoxides as promising anti-leishmanials.
    Sarkar D; Monzote L; Gille L; Chatterjee M
    Phytomedicine; 2024 Jul; 129():155640. PubMed ID: 38714091
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Selenium-Containing (Hetero)Aryl Hybrids as Potential Antileishmanial Drug Candidates: In Vitro Screening against
    Fermiano MH; das Neves AR; da Silva F; Barros MSA; Vieira CB; Stein AL; Frizon TEA; Braga AL; de Arruda CCP; Parisotto EB; Saba S; Rafique J; Riul TB
    Biomedicines; 2024 Jan; 12(1):. PubMed ID: 38255318
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Synthesis of 4-substituted ethers of benzophenone and their antileishmanial activities.
    ; Ahad F; Ghouri N; ; Khan KM; Perveen S; Choudhary MI
    R Soc Open Sci; 2018 May; 5(5):171771. PubMed ID: 29892370
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.